CL
CLVS

CSS LLC’s Clovis Oncology, Inc. CLVS Stock Holding History

CSS LLC’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$70K – 1231
2021
Q1 		$70K Sell
10,000
-138,500
-93% -$929K ﹤0.01% 856
2020
Q4 		$713K Hold
148,500
– – 0.03% 393
2020
Q3 		$865K Hold
148,500
– – 0.04% 319
2020
Q2 		$1M Sell
148,500
-50,000
-25% -$379K 0.06% 263
2020
Q1 		$1.26M Sell
198,500
-25,800
-12% -$207K 0.1% 181
2019
Q4 		$2.33M Buy
224,300
+122,300
+120% +$889K 0.13% 141
2019
Q3 		$400K Buy
102,000
+28,700
+39% +$232K 0.03% 348
2019
Q2 		$1.09M Buy
73,300
+49,300
+205% +$891K 0.06% 207
2019
Q1 		$595K Buy
24,000
+8,000
+50% +$201K 0.04% 280
2018
Q4 		$287K Sell
16,000
-6,000
-27% -$123K 0.02% 342
2018
Q3 		$645K Buy
22,000
+20,000
+1,000% +$774K 0.03% 278
2018
Q2 		$90K Sell
2,000
-17,700
-90% -$861K ﹤0.01% 484
2018
Q1 		$1.04M Sell
19,700
-3,500
-15% -$204K 0.05% 211
2017
Q4 		$1.58M Sell
23,200
-5,000
-18% -$350K 0.08% 170
2017
Q3 		$2.32M Sell
28,200
-8,500
-23% -$674K 0.11% 144
2017
Q2 		$3.44M Sell
36,700
-19,100
-34% -$1.17M 0.17% 113
2017
Q1 		$3.55M Buy
55,800
+5,000
+10% +$304K 0.21% 100
2016
Q4 		$2.26M Buy
+50,800
New +$1.79M 0.12% 146
2016
Q1 		– Sell
-6,000
Closed -$210K – 756
2015
Q4 		$210K Buy
+6,000
New +$387K 0.01% 552

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

CSS LLC's CLVS Position: Q2 2021 in Review

CSS LLC sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 6,000 shares — an estimated $35.2K sold.

CSS LLC first reported a position in CLVS in Q4 2016 and held it in 7 quarters. The position peaked at $277K in Q2 2020. 160 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

  • CSS LLC reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
  • CSS LLC sold 6,000 Clovis Oncology, Inc. shares in Q2 2021, an estimated $35.2K.
  • CSS LLC first reported a position in Clovis Oncology, Inc. in Q4 2016 and held it in 7 quarters.
  • CSS LLC's Clovis Oncology, Inc. position peaked at $277K in Q2 2020.
  • 160 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on CSS LLC's 13F filing for Q2 2021, filed 16 Aug 2021.